Cold Hypersensitivity Clinical Trial
Official title:
Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet : a Randomized, Double-blind, Placebo-controlled Trial
1. Objectives
1. to verify effect of Korean red ginseng on cold hypersensitivity of hands and feet
in women
2. to establish scientific evidence for the use of Korean red ginseng by
investigating changes of infrared thermography
2. Hypothesis The hypothesis is that Korean red ginseng will reduce cold hypersensitivity
of hands and feet more effectively than placebo after 8 weeks administration of
interventions- Korean red ginseng or the placebo.
Design
- This trial is a randomized, double blind, placebo controlled trial with 80 patients.
- The trial will be implemented at Kyung Hee University Hospital at Gangdong in Seoul,
Korea.
- Participants will take Korean red ginseng or placebo for 8 weeks and will be followed
up during 4 weeks.
- During the administration period, 6 capsules 2 times a day (1h after breakfast and
dinner) of Korean red ginseng or its placebo will be provided.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06460194 -
Treatment of Frostbite Sequelae With Botulinum Toxin A
|
Phase 2 | |
Completed |
NCT03083522 -
Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and Feet
|
Phase 3 | |
Completed |
NCT03374345 -
Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)
|
Phase 2/Phase 3 | |
Completed |
NCT02645916 -
Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands
|
Phase 4 | |
Completed |
NCT03790033 -
Efficacy and Safety of Ucha-Shinki-Hwan on Korean Patients With Cold Hypersensitivity in the Hands and Feet-Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial
|
Phase 2/Phase 3 |